Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:927589.
doi: 10.1155/2015/927589. Epub 2015 Feb 28.

Association of IL-6 polymorphism -174G/C and metabolic syndrome in hypertensive patients

Affiliations

Association of IL-6 polymorphism -174G/C and metabolic syndrome in hypertensive patients

Andrei Alkmim Teixeira et al. Biomed Res Int. 2015.

Abstract

Introduction: Visceral obesity, the central core of metabolic syndrome (MetS), is conceived as the pathogenic basis of an increased cardiovascular burden and is related with changes in cytokines. We investigated whether IL-6-174G/C gene polymorphism is associated with MetS prevalence in hypertensive patients.

Method: A population of hypertensive patients was included and stratified by the presence of MetS according to IDF criteria and evaluated by Framingham risk score. The IL-6-174G/C genotyping was performed by polymerase chain reaction and the prevalence of MetS was compared between "C" carrier and "non-C" carrier groups.

Results: From an original sample of 664 patients, 612 (34.2% men, age 57.3 ± 10.1, 30.4% diabetics) were included. MetS was diagnosed in 51.3% of total population and "C" carriers demonstrated high prevalence of MetS (P < 0.05) and each of its components. On binary logistic regression, it was observed that the IL-6 polymorphism was independently associated with occurrence of MetS, even after adjusting for covariates (OR 1.13-2.37, 95% CI, P < 0.05).

Conclusion: The C allele at the -174 locus of IL-6 gene is independently associated with the occurrence of metabolic syndrome, emphasizing the importance of inflammatory genetic background in the pathogenesis of visceral obesity and related cardiovascular burden.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MetS+ and MetS IL-6 genotype frequency. *(P < 0.05).

References

    1. Lakka H.-M., Laaksonen D. E., Lakka T. A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. The Journal of the American Medical Association. 2002;288(21):2709–2716. doi: 10.1001/jama.288.21.2709. - DOI - PubMed
    1. Lempiainen P., Mykkanen L., Pyorala K., Laakso M., Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly non-diabetic men. Circulation. 1999;100:123–128. doi: 10.1161/01.cir.100.2.123. - DOI - PubMed
    1. Kuusisto J., Lempiainen P., Mykkanen L., Laakso M. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care. 2001;24(9):1629–1633. doi: 10.2337/diacare.24.9.1629. - DOI - PubMed
    1. Onat A., Ceyhan K., Başar Ö., Erer B., Toprak S., Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165(2):285–292. doi: 10.1016/s0021-9150(02)00236-8. - DOI - PubMed
    1. Alexander C. M., Landsman P. B., Teutsch S. M., Haffner S. M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52(5):1210–1214. doi: 10.2337/diabetes.52.5.1210. - DOI - PubMed

Publication types

LinkOut - more resources